Johnson & Johnson (JNJ) Inventory (2009 - 2026)

Johnson & Johnson (JNJ) posted Inventory of $14.6 billion for Q1 2026, up 2.76% sequentially from $14.2 billion in Q4 2025, and up 15.2% YoY from $12.7 billion in Q1 2025.

Johnson & Johnson (JNJ) Inventory (2009 - 2026) Analysis & Trends

Johnson & Johnson (JNJ) has 18 years of Inventory data on file, last reported at $14.6 billion in Q1 2026.

  • Quarterly Inventory rose 15.2% year-over-year to $14.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.6 billion (up 15.2% YoY) and the FY2025 annual result came in at $14.2 billion, up 14.04% from the prior year.
  • Inventory rose to $14.6 billion in Q1 2026 per JNJ's latest filing, from $14.2 billion in the prior quarter.
  • The five-year high for Inventory was $14.6 billion in Q1 2026, with the low at $10.3 billion in Q1 2023.
  • Average Inventory over 5 years is $12.2 billion, with a median of $12.3 billion recorded in 2024.
  • Year-over-year, Inventory grew 16.55% in 2023 and slipped 11.13% in 2024.
  • Johnson & Johnson's Inventory stood at $11.7 billion in 2022, then declined by 4.23% to $11.2 billion in 2023, then gained by 11.3% to $12.4 billion in 2024, then climbed by 14.04% to $14.2 billion in 2025, then increased by 2.76% to $14.6 billion in 2026.
  • Business Quant data shows JNJ's Inventory at $14.6 billion in Q1 2026, $14.2 billion in Q4 2025, and $14.1 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 14.53 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 14.58 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 5.05 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 6.57 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 6.48 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 6.19 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 1.91 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 10.67 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn 1.95 Bn

Historic Data

Download Data
DateValue
Mar 29, 2026 14.58 Bn
Dec 28, 2025 14.19 Bn
Sep 28, 2025 14.15 Bn
Jun 29, 2025 13.41 Bn
Mar 30, 2025 12.66 Bn
Dec 29, 2024 12.44 Bn
Sep 29, 2024 12.60 Bn
Jun 30, 2024 12.17 Bn
Mar 31, 2024 11.38 Bn
Dec 31, 2023 11.18 Bn
Oct 1, 2023 11.20 Bn
Jul 2, 2023 12.89 Bn
Apr 2, 2023 12.81 Bn
Jan 1, 2023 10.27 Bn
Oct 2, 2022 11.68 Bn
Jul 3, 2022 11.44 Bn
Apr 3, 2022 10.99 Bn
Jan 2, 2022 10.39 Bn
Oct 3, 2021 10.39 Bn
Jul 4, 2021 10.10 Bn